Impact of positron emission tomography with computed tomography for image-guided radiotherapy.
Carcinoma, Non-Small-Cell Lung
/ diagnostic imaging
Carcinoma, Squamous Cell
/ diagnostic imaging
Esophageal Neoplasms
/ diagnostic imaging
Female
Genital Neoplasms, Female
/ diagnostic imaging
Head and Neck Neoplasms
/ diagnostic imaging
Humans
Lung Neoplasms
/ diagnostic imaging
Lymphatic Metastasis
/ diagnostic imaging
Lymphoma
/ diagnostic imaging
Male
Positron Emission Tomography Computed Tomography
/ methods
Prognosis
Prostatic Neoplasms
/ diagnostic imaging
Radiotherapy Dosage
Radiotherapy, Image-Guided
/ methods
Adaptative radiation
PET
Radiotherapy
Radiothérapie
Radiothérapie adaptative
TEP
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
02
12
2019
revised:
10
03
2020
accepted:
12
03
2020
pubmed:
15
4
2020
medline:
23
7
2020
entrez:
15
4
2020
Statut:
ppublish
Résumé
Therapeutic effectiveness in radiotherapy is partly related to correct staging of the disease and then precise therapeutic targeting. Positron emission tomography (PET) allows the stage of many cancers to be determined and therefore is essential before deciding on radiation treatment. The definition of the therapeutic target is essential to obtain correct tumour control and limit side effects. The part of adaptive radiotherapy remains to be defined, but PET by its functional nature makes it possible to define the prognosis of many cancers and to consider radiotherapy adapted to the initial response allowing an increase over the entire metabolic volume, or targeted at a subvolume at risk per dose painting, or with a decrease in the dose in case of good response at interim assessment.
Identifiants
pubmed: 32284178
pii: S1278-3218(20)30076-7
doi: 10.1016/j.canrad.2020.03.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
362-367Informations de copyright
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.